Related Experiment Video
Updated: May 13, 2026

10:12
Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization
Published on: May 15, 2018
Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.
Ellen Heitzer1, Martina Auer, Christin Gasch
1Institute of Human Genetics, Medical University of Graz, Graz, Austria.
Cancer Research
|March 9, 2013
Summary
Genomic profiling of circulating tumor cells (CTCs) in colorectal cancer patients reveals mutations present in both primary tumors and metastases. This supports using CTCs as a liquid biopsy for monitoring evolving cancer genotypes.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Circulating tumor cells (CTCs) reflect dynamic tumor genotypes.
- Monitoring genetic changes in cancer is crucial for effective treatment.
Purpose of the Study:
- To perform comprehensive genomic profiling of CTCs.
- To compare genetic mutations in CTCs with primary tumors and metastases.
- To establish CTCs as a liquid biopsy for cancer monitoring.
Main Methods:
- Utilized array-comparative genomic hybridization (CGH) and next-generation sequencing.
- Employed the CellSearch system for CTC detection in stage IV colorectal carcinoma patients.
- Performed massive parallel sequencing on CTCs, primary tumors, and metastases.
Main Results:
- Detected colorectal cancer-associated copy number changes in isolated CTCs, often shared with primary tumors.
- Found mutations in known driver genes (APC, KRAS, PIK3CA) in CTCs that were also present in primary tumors and metastases.
- Identified mutations exclusively in CTCs, which were mostly present at subclonal levels in primary tumors/metastases.
Conclusions:
- CTCs harbor genetic alterations mirroring those in primary tumors and metastases.
- CTCs can serve as a valuable non-invasive liquid biopsy for tracking tumor evolution.
- This approach offers enhanced options for monitoring cancer progression, treatment response, and relapse.

